CannaLnx Vision

Clarity that patients—and providers—can act on.

EM2P2/CannaLnx envisions a world in which cannabinoid medicine is ordinary and essential, seamlessly integrated into mainstream healthcare (through collaboration, not competition), and its advantages fully realized after nearly 100 years of unwarranted stigma, lost medical opportunity, and needless suffering.

Empowering millions of underserved patients to optimize wellness outcomes and quality of life by:

1. Guiding the medical-cannabis industry from chaos to competence and financial strength.
2. Bridging the information gap between patients, doctors, and dispensaries.
3. Combining and streamlining programming and biometric technologies that measure the impact of therapies and behaviors on wellness.
4. Redefining and broadening access to, understanding and acceptance of, and assistance with alternative cannabinoid therapies.
5. Turning data into high-use information that yields real healing.